文献速递主动脉疾病外周动脉疾病

腹腔镜与开放主双股动脉旁路术的挪威随机试验:NLAST

Editor's Choice - Norwegian Randomised Trial of Laparoscopic versus Open Aortobifemoral Bypass: The Norwegian Laparoscopic Aortic Surgery Trial (NLAST).
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-11-07

NLAST 是多中心随机对照优势试验,纳入 126 例 TASC II D 型主髂动脉闭塞性疾病患者,1:1 随机接受腹腔镜或开放主双股动脉旁路术。腹腔镜组术后并发症发生率为 34%,开放组为 73%,差异显著(p < .001),30 天死亡率均为 2%。

要点

  • 腹腔镜主双股动脉旁路术可显著减少 TASC II D 型主髂动脉闭塞患者的术后并发症。
  • 两组 30 天死亡率均为 2%,围手术期安全性相当。
  • 术后 1 年和 2 年通畅率两组均较高,腹腔镜组数值略优。

核心结论

  • 对于 TASC II D 型主髂动脉闭塞性疾病患者,腹腔镜主双股动脉旁路术较开放手术显著减少术后并发症。

研究设计与样本

  • 共纳入 126 例 TASC II D 型病变、Fontaine IIb 级或更差的患者,按 1:1 随机分配至腹腔镜组(n = 63)或开放组(n = 63)。
  • 主要结局为随访 2.9 年期间的术后并发症(包括全身性、血管性和局部并发症),主要分析采用意向性治疗原则。

主要发现

  • 腹腔镜组 62 例(98%)和开放组 60 例(95%)完成了分配的手术。
  • 腹腔镜组术后并发症发生率为 34%(21/62),开放组为 73%(44/60),差异为 -40 个百分点(95% CI -54 至 -22;p < .001),平均随访 3.6 ± 2.5 年。
  • 腹腔镜组和开放组 30 天死亡率均为 2%(分别为 1/62 和 1/60)。
  • 术后 1 年腹腔镜组的一期、一期辅助和二期通畅率均为 98%,开放组分别为 95%、96% 和 96%。
  • 术后 2 年腹腔镜组的一期、一期辅助和二期通畅率均为 98%,开放组分别为 94%、95% 和 95%。

临床怎么用

  • 对于适合手术的 TASC II D 型主髂动脉闭塞性疾病患者,腹腔镜主双股动脉旁路术可作为一种并发症更少的选项。
  • 临床决策时应结合患者病变解剖条件、合并症及术者腹腔镜技术经验综合评估。

局限性

  • 试验为非盲设计,可能存在偏倚风险。
  • 样本量较小(共 126 例),结论需更大规模研究验证。
  • 随访时间有限(平均 3.6 年),长期通畅率和并发症情况尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to compare post-operative complications after laparoscopic and open aortobifemoral bypass (ABFB) for aorto-iliac occlusive disease (AIOD). METHODS: The Norwegian Laparoscopic Aortic Surgery Trial (NLAST) is a multicentre, non-blinded, parallel group, randomised controlled superiority trial. The trial was funded by Oslo University Hospital and conducted at three Norwegian public hospitals between March 2013 and November 2022. In this randomised study, 126 patients with TransAtlantic InterSociety Consensus II (TASC II) type D lesions, with debilitating lifestyle limiting intermittent claudication or chronic limb threatening ischaemia, clinically classified as Fontaine IIb or worse, were randomised in a 1:1 ratio to either laparoscopic ABFB (n = 63) or open ABFB (n = 63) (ClinicalTrials.gov ID NCT01793662). The primary outcome was post-operative complications, including systemic, vascular, and local complications, during a follow up of 2.9 years. The primary analysis was conducted on an intention to treat basis, with an additional supporting analysis performed per protocol. RESULTS: Allocated surgery was performed in 62 (98%) and 60 (95%) individuals in the laparoscopic and open ABFB groups, respectively. Post-operative complications occurred in 21/62 patients (34%) in the laparoscopic group and 44/60 patients (73%) in the open ABFB group (difference -40 percentage points, 95% confidence interval -54 - -22; p < .001), during a mean follow up of 3.6 ± 2.5 years. The 30 day mortality rate was 2% (1/62) and 2% (1/60) for laparoscopic and open ABFB, respectively. Limb based primary patency, primary assisted patency, and secondary patency rates at one year were 98%, 98%, and 98% for laparoscopic ABFB and 95%, 96%, and 96% for open ABFB, respectively. At two years the rates were 98%, 98%, and 98% for laparoscopic ABFB and 94%, 95%, and 95% for open ABFB. CONCLUSION: Patients with AIOD, TASC II type D lesions have significantly fewer post-operative complications after laparoscopic than open ABFB.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kazmi SSH, Sahba M, Pettersen EM, et al. Editor's Choice - Norwegian Randomised Trial of Laparoscopic versus Open Aortobifemoral Bypass: The Norwegian Laparoscopic Aortic Surgery Trial (NLAST). Eur J Vasc Endovasc Surg. 2025. PMID: 41207501. doi:10.1016/j.ejvs.2025.09.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。